If you think ARNA is headed higher click

If you think ARNA is headed lower click

ARNA

Arena Pharmaceuticals, Inc.

Recent Community Picks
FCX AAPL ISF UAUA TZA SPY CF MMYT	ORCL GS SHLD JPM BCON PFE FSLR NFLX

Last Trade: 6.86
%Change: +1.78%
Volume Analysis
Average Volume: 9258720
Half Hour Run Rate: 712209
1 Minute Run Rate: 23740
Run Rate Based: 9258600
Current Volume: 5778803
P/E: N/A
Market Cap: 770.7M
52 Week High: 8.00
52 Week Low: 2.70
Next Year EPS: -0.55
Twitter Updates: ARNA

ARNA - Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. The Company's drug candidate, lorcaserin hydrochloride (lorcaserin), is being investigated in a Phase III clinical trial program for the treatment of obesity. It has a pipeline of compounds that target G protein-coupled receptors (GPCRs), and includes compounds being evaluated independently and with its partners, including Merck & Co., Inc. (Merck) and Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ortho-McNeil-Janssen). On January 9, 2008, the Company acquired from Siegfried Ltd certain drug product facility assets, including a licensed production facility, fixtures, equipment, other personal property and real estate assets in Zofingen, Switzerland.

Derivatives Risk Management

© Big Moving Stock About | Disclaimer | Advertise | User Manual